Meaning of UroLift (Prostatic Urethral Lift) Implant Placement
UroLift (prostatic urethral lift, PUL) is a minimally invasive procedure in which small permanent implants are placed in the prostate to mechanically retract obstructing prostate tissue and widen the prostatic urethral lumen. [1] UroLift is indicated to treat lower urinary tract symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 years and older. [2]
What “implants placed in the prostate” involves
During PUL, implants are deployed through the urethra to pull obstructing prostate lobes away from the urethral channel. [1] These implants remain in place permanently and function as mechanical spacers to maintain increased urethral patency. [1]
Relationship to urgency urinary incontinence (urge UI)
Urgency urinary incontinence is typically part of overactive bladder physiology, which can coexist with BPH. [3] UroLift is primarily a BPH/LUTS-directed treatment for obstruction-related symptoms. [2] If urinary urgency and incontinence symptoms are driven in part by bladder outlet obstruction from BPH, symptom improvement can occur after PUL. [2] If urgency urinary incontinence reflects predominant overactive bladder rather than obstruction, persistence of urgency or incontinence after PUL remains possible. [3]
Patient-selection implications
For BPH symptom management, PUL is considered an option when prostate size is less than 80 g and an obstructive middle lobe is absent. [3] Patients should be informed that symptom reduction and urine flow improvement with PUL are less pronounced than with more invasive resection approaches such as TURP. [3]
Expected short-term urinary side effects after implant placement
Treatment-related short-term urinary events reported with PUL compared with sham include dysuria, hematuria, pelvic pain/discomfort, urgency, bladder spasm, urinary tract infection, and urinary retention. [3]
Practical meaning of undergoing this procedure for this specific condition pairing
Proceeding with UroLift for both BPH and urge UI generally indicates an assessment that bladder outlet obstruction from BPH may be contributing to the urgency/incontinence symptoms. [2] Ongoing overactive bladder therapy may still be needed after PUL if urge symptoms do not adequately resolve. [3]
Information to confirm with the treating clinician
Confirmation of prostate volume and presence or absence of an obstructive middle lobe is important because PUL eligibility depends on these factors. [3] Clarification of whether the urge urinary incontinence is expected to improve mainly due to relief of obstruction versus expected to require separate overactive bladder treatment helps set symptom expectations. [2][3]